• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨小梁骨评分和骨矿表观密度与成骨不全症患儿和青少年骨脆弱性严重程度的相关性:一项横断面研究。

Association of trabecular bone score and bone mineral apparent density with the severity of bone fragility in children and adolescents with osteogenesis imperfecta: A cross-sectional study.

机构信息

Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

出版信息

PLoS One. 2023 Aug 29;18(8):e0290812. doi: 10.1371/journal.pone.0290812. eCollection 2023.

DOI:10.1371/journal.pone.0290812
PMID:37643181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10464990/
Abstract

Osteogenesis imperfecta (OI) is a hereditary skeletal disease characterized by bone fragility. Areal bone mineral density (BMD), evaluated by dual-energy X-ray absorptiometry (DXA), is used to assess bone brittleness. The height-adjusted BMD Z-score (BMDHAZ) is calculated in children and adolescents with OI to reduce the confounding factor of short stature. However, even with the BMDHAZ, severity evaluation in children and adolescents with OI is challenging because certain abnormalities in bone quality cannot be accurately assessed by BMD analysis. The trabecular bone scores (TBS) and bone mineral apparent density (BMAD), which represent the structural integrity of bone and bone-size-associated BMD, respectively, are associated with fracture risk. Recently, age- and sex-specific reference ranges have been reported, enabling the calculation of Z-scores for children. To evaluate which density measurements show the highest correlation with fracture risk, we analyzed the associations between the Z-scores of TBS, BMAD, and BMDHAZ, fracture rate, and genetic variants. We retrospectively reviewed 42 participants with OI aged 5 to 20 years who underwent DXA. COL1A1/2 pathogenic variants were detected in 41 of the 42 participants. In participants with nonsense and frameshift variants (n = 17) resulting in haploinsufficiency and mild phenotype, the TBS Z-score was negatively correlated with fracture rate (FR) (r = -0.50, p = 0.042). In participants with glycine substitution (n = 9) causing the severe phenotype, the BMAD Z-scores were negatively correlated with FR (r = -0.74, p = 0.022). No correlation between the BMDHAZ and FR was observed in both groups. These findings suggest that the TBS and BMAD are useful in assessing children and adolescents with OI with specific genetic variants.

摘要

成骨不全症(OI)是一种遗传性骨骼疾病,其特征为骨骼脆弱。通过双能 X 射线吸收法(DXA)评估的面积骨密度(BMD)用于评估骨骼脆性。OI 患儿和青少年的身高调整骨密度 Z 评分(BMDHAZ)用于降低身高偏矮的混杂因素。然而,即使有了 BMDHAZ,OI 患儿和青少年的严重程度评估仍然具有挑战性,因为骨质量的某些异常无法通过 BMD 分析准确评估。骨小梁评分(TBS)和骨矿密度表观密度(BMAD)分别代表骨骼结构完整性和与骨大小相关的 BMD,与骨折风险相关。最近,已经报道了年龄和性别特异性参考范围,能够为儿童计算 Z 评分。为了评估哪种密度测量与骨折风险相关性最高,我们分析了 TBS、BMAD 和 BMDHAZ 的 Z 评分、骨折率和遗传变异之间的关联。我们回顾性分析了 42 名年龄在 5 至 20 岁的 OI 患者,这些患者均接受了 DXA 检查。在 42 名患者中,有 41 名检测到 COL1A1/2 致病性变异。在导致杂合不足和轻度表型的无义和移码变异(n = 17)的患者中,TBS Z 评分与骨折率(FR)呈负相关(r = -0.50,p = 0.042)。在引起严重表型的甘氨酸替代(n = 9)患者中,BMAD Z 评分与 FR 呈负相关(r = -0.74,p = 0.022)。在这两组患者中,BMDHAZ 与 FR 之间均无相关性。这些发现表明 TBS 和 BMAD 可用于评估具有特定遗传变异的 OI 患儿和青少年。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f1/10464990/939351f1f289/pone.0290812.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f1/10464990/b2533d630da8/pone.0290812.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f1/10464990/7fbb4714c219/pone.0290812.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f1/10464990/939351f1f289/pone.0290812.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f1/10464990/b2533d630da8/pone.0290812.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f1/10464990/7fbb4714c219/pone.0290812.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f1/10464990/939351f1f289/pone.0290812.g003.jpg

相似文献

1
Association of trabecular bone score and bone mineral apparent density with the severity of bone fragility in children and adolescents with osteogenesis imperfecta: A cross-sectional study.骨小梁骨评分和骨矿表观密度与成骨不全症患儿和青少年骨脆弱性严重程度的相关性:一项横断面研究。
PLoS One. 2023 Aug 29;18(8):e0290812. doi: 10.1371/journal.pone.0290812. eCollection 2023.
2
Trabecular Bone Score Reference Values for Children and Adolescents According to Age, Sex, and Ancestry.根据年龄、性别和血统划分的儿童及青少年小梁骨评分参考值
J Bone Miner Res. 2022 Apr;37(4):776-785. doi: 10.1002/jbmr.4520. Epub 2022 Feb 23.
3
Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta.通过高分辨率外周定量计算机断层扫描(HR-pQCT)、骨小梁评分(TBS)和双能X线吸收法(DXL)评估不同类型成骨不全成年患者的骨结构。
Osteoporos Int. 2015 Oct;26(10):2431-40. doi: 10.1007/s00198-015-3156-4. Epub 2015 May 9.
4
Imaging in osteogenesis imperfecta: Where we are and where we are going.成骨不全症的影像学表现:现状与未来。
Eur J Med Genet. 2024 Apr;68:104926. doi: 10.1016/j.ejmg.2024.104926. Epub 2024 Feb 16.
5
Changes in trabecular bone score and bone density in female adolescents with anorexia nervosa: a longitudinal study.女性青少年神经性厌食症患者的小梁骨评分和骨密度变化:一项纵向研究。
J Clin Densitom. 2022 Jul-Sep;25(3):416-423. doi: 10.1016/j.jocd.2021.11.004. Epub 2021 Nov 19.
6
TBS as a Tool to Differentiate the Impact of Antiresorptives onCortical and Trabecular Bone in Children With OsteogenesisImperfecta.用 TBS 区分抗再吸收药物对成骨不全症患儿皮质骨和松质骨的影响
J Clin Densitom. 2019 Apr-Jun;22(2):229-235. doi: 10.1016/j.jocd.2018.09.001. Epub 2018 Sep 8.
7
Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.79名患有I型、III型和IV型成骨不全症的瑞典儿童接受帕米膦酸盐治疗后的骨折率降低、药物遗传学及骨密度反应
Bone. 2016 Jun;87:11-8. doi: 10.1016/j.bone.2016.02.015. Epub 2016 Mar 5.
8
Differing lumbar vertebral mineralization rates in ambulatory pediatric patients with osteogenesis imperfecta.活动期成骨不全小儿患者腰椎椎体矿化率的差异
Calcif Tissue Int. 1998 Jan;62(1):17-20. doi: 10.1007/s002239900387.
9
Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1.COL1A1 基因杂合性缺失突变导致成骨不全症的骨骼临床特征。
J Bone Miner Res. 2013 Sep;28(9):2001-7. doi: 10.1002/jbmr.1942.
10
Evaluation of the trabecular bone score in 35 children and adults with X-linked hypophosphatemic rickets.评估 35 名 X 连锁低磷血症性佝偻病儿童和成人的小梁骨评分。
J Bone Miner Metab. 2023 Sep;41(5):666-672. doi: 10.1007/s00774-023-01442-x. Epub 2023 Jul 7.

引用本文的文献

1
Reference curves for trabecular bone score adjusted for soft tissue thickness in children and adolescents from Mexico City.墨西哥城儿童和青少年经软组织厚度校正的小梁骨评分参考曲线。
Arch Osteoporos. 2025 Aug 6;20(1):110. doi: 10.1007/s11657-025-01595-4.
2
Osteogenesis imperfecta: pathogenesis, classification, and treatment.成骨不全症:发病机制、分类及治疗
Clin Pediatr Endocrinol. 2025 Jul;34(3):152-161. doi: 10.1297/cpe.2025-0009. Epub 2025 Mar 31.
3
Bone Mineral Density and Trabecular Bone Score in Children, Adolescents and Young Adults with Familial Dysautonomia.

本文引用的文献

1
Trabecular bone score (TBS) and bone mineral density (BMD) analysis by dual X-ray absorptiometry (DXA) in healthy Brazilian children and adolescents: normative data.双能 X 射线吸收法(DXA)检测健康巴西儿童和青少年的小梁骨骨密度(TBS)和骨密度(BMD)分析:正常值。
Arch Osteoporos. 2023 Jun 15;18(1):82. doi: 10.1007/s11657-023-01291-1.
2
Trabecular Bone Score Reference Values for Children and Adolescents According to Age, Sex, and Ancestry.根据年龄、性别和血统划分的儿童及青少年小梁骨评分参考值
J Bone Miner Res. 2022 Apr;37(4):776-785. doi: 10.1002/jbmr.4520. Epub 2022 Feb 23.
3
Sarcopenia and preserved bone mineral density in paediatric survivors of high-risk neuroblastoma with growth failure.
患有家族性自主神经功能异常的儿童、青少年和年轻成年人的骨密度和小梁骨评分
Calcif Tissue Int. 2025 Jun 24;116(1):88. doi: 10.1007/s00223-025-01400-x.
4
Bone health: Quality versus quantity.骨骼健康:质量与数量
J Pediatr Soc North Am. 2024 Apr 7;7:100054. doi: 10.1016/j.jposna.2024.100054. eCollection 2024 May.
5
Bone health and bisphosphonate treatment in females with Rett syndrome in a national center.在一个国家级中心对患有雷特综合征的女性进行的骨骼健康与双膦酸盐治疗
Pediatr Res. 2025 Mar 21. doi: 10.1038/s41390-025-04001-4.
6
TBS as a complementary tool for assessing vertebral fractures and spinal deformity in children and adolescents with osteogenesis imperfecta.TBS作为评估成骨不全儿童和青少年椎体骨折及脊柱畸形的辅助工具。
Osteoporos Int. 2025 Apr;36(4):725-735. doi: 10.1007/s00198-025-07423-2. Epub 2025 Feb 24.
7
Low bone mineral density and its influencing factors in spinal muscular atrophy without disease-modifying treatment: a single-centre cross-sectional study.脊髓性肌萎缩症患者在未接受疾病修正治疗时的骨矿物质密度降低及其影响因素:一项单中心横断面研究。
BMC Pediatr. 2024 Oct 11;24(1):651. doi: 10.1186/s12887-024-05120-3.
8
Osteoporosis and Bone Fragility in Children: Diagnostic and Treatment Strategies.儿童骨质疏松症与骨脆性:诊断与治疗策略
J Clin Med. 2024 Aug 22;13(16):4951. doi: 10.3390/jcm13164951.
9
Beneficial effects of romosozumab on bone mineral density and trabecular bone score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis imperfecta.在一个成骨不全家族中,使用双能X线吸收法评估罗莫单抗对骨矿物质密度和小梁骨评分的有益作用。
Osteoporos Int. 2024 Jul;35(7):1303-1304. doi: 10.1007/s00198-024-07089-2. Epub 2024 May 8.
高危神经母细胞瘤生长障碍患儿的肌肉减少症和骨密度正常。
J Cachexia Sarcopenia Muscle. 2021 Aug;12(4):1024-1033. doi: 10.1002/jcsm.12734. Epub 2021 Jun 29.
4
Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.成骨不全症:连接经典型和罕见型 OI 类型的机制和信号通路。
Endocr Rev. 2022 Jan 12;43(1):61-90. doi: 10.1210/endrev/bnab017.
5
Management of primary and secondary osteoporosis in children.儿童原发性和继发性骨质疏松症的管理。
Ther Adv Musculoskelet Dis. 2020 Nov 2;12:1759720X20969262. doi: 10.1177/1759720X20969262. eCollection 2020.
6
Vertebral fracture assessment (VFA) for monitoring vertebral reshaping in children and adolescents with osteogenesis imperfecta treated with intravenous neridronate.静脉用奈立膦酸钠治疗成骨不全症患儿和青少年的椎体重塑监测:椎体骨折评估(VFA)。
Bone. 2021 Feb;143:115608. doi: 10.1016/j.bone.2020.115608. Epub 2020 Aug 20.
7
Bone densities and bone geometry in children and adolescents with arthrogryposis.关节挛缩症患儿和青少年的骨密度和骨几何结构。
Bone. 2020 Aug;137:115454. doi: 10.1016/j.bone.2020.115454. Epub 2020 May 25.
8
Correction to: Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta.对《53例日本成骨不全患者采用靶向新一代测序技术进行的综合基因分析及基因型-表型相关性研究》的更正
Osteoporos Int. 2020 Jun;31(6):1185. doi: 10.1007/s00198-020-05396-y.
9
Nosology and classification of genetic skeletal disorders: 2019 revision.遗传骨骼疾病的命名学和分类:2019 修订版。
Am J Med Genet A. 2019 Dec;179(12):2393-2419. doi: 10.1002/ajmg.a.61366. Epub 2019 Oct 21.
10
A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta.一项多中心观察性队列研究,旨在评估双膦酸盐暴露对成骨不全症患者骨密度及其他健康结局的影响。
JBMR Plus. 2019 Jan 7;3(5):e10118. doi: 10.1002/jbm4.10118. eCollection 2019 May.